NASDAQ · Financial Statements

Health In Tech, Inc. (HIT) Financial Statements

$0.56 NASDAQ: HIT Market Cap $30.14M

Health In Tech, Inc. most recently reported annual revenue of $33.0M, net profit of $1.0M. Revenue grew at an average annual rate of 76.5% over the last 3 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Health In Tech, Inc.: Revenue rose from $6.0M in 2022 to $33.0M in 2025, a change of +450.0% over 3 years; net profit was positive in 3 of 4 reported years; operating margin moved from 3.6% to 4.6%, a shift of +1.0 percentage points; the most recent year shows net profit of $1.0M.

Income Statement — 4 Years (USD millions)

Metric2022202320242025
Revenue$6.0M$19.0M$19.0M$33.0M
Operating Expenses$6.0M$16.0M$19.0M$32.0M
Operating Profit$0$3.0M$1.0M$2.0M
Operating Margin3.6%17.7%5.1%4.6%
Other Income$0$0$0$0
Interest$0$0$0$0
Depreciation$0$0$1.0M$1.0M
Profit Before Tax$0$3.0M$1.0M$2.0M
Tax$60.3M$27.6M$24.6M$23.6M
Net Profit$0$2.0M$1.0M$1.0M
EPS$0.00$0.05$0.01$0.02
Dividend Payout0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

2 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$5.0M$5.0M$5.0M$5.0M$4.0M$5.0M$8.0M$9.0M$8.0M$8.0M$9.0M$8.0M
Operating Expenses$5.0M$4.0M$5.0M$4.0M$4.0M$5.0M$8.0M$9.0M$8.0M$8.0M$11.0M$11.0M
Operating Profit$1.0M$1.0M$0$1.0M$0$0$0$1.0M$0$0$-2.0M$-3.0M
Operating Margin9.9%27.9%6.5%10.7%9.8%-6.5%6.0%7.8%5.8%-2.3%-24.6%-42.7%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax$1.0M$1.0M$0$0$0$0$1.0M$1.0M$1.0M$0$-2.0M$-3.0M
Tax$24.4M$32.3M$47.6M$15.8M$7.5M$-30.2M$27.1M$24.3M$24.7M$31.8M$23.2M$24.4M
Net Profit$0$1.0M$0$0$0$0$0$1.0M$0$0$-2.0M$-3.0M
EPS$0.01$0.02$0.00$0.01$0.01$0.00$0.01$0.01$0.01$-0.01$-0.03$-0.04

Over the 4 years reported for Health In Tech, Inc., cash stood at $8.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 3.20 times.

Balance Sheet — 4 Years (USD millions)

Metric2022202320242025
Total Assets$29.0M$12.0M$16.0M$23.0M
Current Assets$25.0M$7.0M$11.0M$16.0M
Cash$1.0M$2.0M$8.0M$8.0M
Inventory$0$0$0$0
Receivables$1.0M$4.0M$2.0M$5.0M
Fixed Assets$0$0$0$0
Capital Work in Progress$0$0$0$0
Investments$0$0$0$0
Other Assets$0$0$0$0
Total Liabilities$27.0M$5.0M$3.0M$6.0M
Current Liabilities$24.0M$5.0M$2.0M$5.0M
Borrowings$0$2.0M$0$0
Other Liabilities$27.0M$3.0M$2.0M$6.0M
Equity$0$0$0$0
Reserves$1.0M$6.0M$13.0M$17.0M

For Health In Tech, Inc., operating cash flow was positive in 4 of 4 reported years; free cash flow in the latest year was $0; free cash flow was positive in 1 of 4 years.

Cash Flow Statement — 4 Years (USD millions)

Metric2022202320242025
Operating Cash Flow$1.0M$2.0M$2.0M$3.0M
Investing Cash Flow$-2.0M$-3.0M$-2.0M$-6.0M
Financing Cash Flow$0$0$-2.0M$0
Net Cash Flow$1.0M$1.0M$5.0M$0
Free Cash Flow$0$0$1.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.37
EV / EBITDA-8.20
FCF Yield-10.25%
Quick Ratio2.17
Interest Coverage—
Return 1Y-5.96%
Return 3Y—
Return 5Y—

Health In Tech, Inc. (HIT) financials — frequently asked questions

What is Health In Tech, Inc.'s annual revenue?

Health In Tech, Inc. (HIT) reported annual revenue of $33.0M in its most recent fiscal year.

What is Health In Tech, Inc.'s net profit?

Health In Tech, Inc. (HIT) reported net profit of $1.0M in its most recent fiscal year.

What is HIT EV/EBITDA?

Health In Tech, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -8.20. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Technology StocksLow P/E Technology StocksHigh Net Margin Technology StocksDividend Technology StocksLow Debt Technology StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
HIT Overview HIT Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.